BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6882509)

  • 1. Influence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells.
    Watanabe K; Tanaka K
    Atherosclerosis; 1983 Jul; 48(1):57-70. PubMed ID: 6882509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin-mediated vascular injury: demonstration of vascular endothelial cell retraction in response to soluble fibrin-associated factors.
    Rowland FN; Donovan MJ; Picciano PT; Kreutzer DL
    J Exp Pathol; 1984; 1(3):217-40. PubMed ID: 6599938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture.
    Ishida T; Tanaka K
    Atherosclerosis; 1982 Aug; 44(2):161-74. PubMed ID: 7138618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen degradation products influence PGI2 synthesis by cultured porcine aortic endothelial and smooth muscle cells.
    Watanabe K; Ishida T; Yoshitomi F; Tanaka K
    Atherosclerosis; 1984; 51(2-3):151-61. PubMed ID: 6430306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin alphavbeta3-RGDS interaction mediates fibrin-induced morphological changes of glomerular endothelial cells.
    Xu Q; Chen X; Fu B; Ye Y; Yu L; Wang J; Li W; Cheng Q
    Kidney Int; 1999 Oct; 56(4):1413-22. PubMed ID: 10504493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D.
    Dang CV; Bell WR; Kaiser D; Wong A
    Science; 1985 Mar; 227(4693):1487-90. PubMed ID: 4038818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fibrinogen degradation products on glomerular mesangial cells in culture.
    Tsumagari T; Tanaka K
    Kidney Int; 1984 Nov; 26(5):712-8. PubMed ID: 6521256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of fibrin-induced disorganization of cultured human endothelial cell monolayers.
    Weimar B; Delvos U
    Arteriosclerosis; 1986; 6(2):139-45. PubMed ID: 3513750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin: mediator of in vivo and in vitro injury and inflammation.
    Rowland FN; Donovan MJ; Gillies C; O'Rourke J; Kreutzer DL
    Curr Eye Res; 1985 May; 4(5):537-53. PubMed ID: 3874755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fibrin degradation products and thrombin on fibrinogen synthesis.
    Ittyerah TR; Weidner N; Wochner RD; Sherman LA
    Br J Haematol; 1979 Dec; 43(4):661-8. PubMed ID: 526446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and B.
    Kessler CM; Bell WR
    J Lab Clin Med; 1979 May; 93(5):758-67. PubMed ID: 429874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific fibrinogen and thrombin concentrations promote neuronal rather than glial growth when primary neural cells are seeded within plasma-derived fibrin gels.
    Mooney R; Tawil B; Mahoney M
    Tissue Eng Part A; 2010 May; 16(5):1607-19. PubMed ID: 20028220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stimulatory capacity of soluble fibrin prepared from high and low molecular weight fibrinogen on plasminogen activation.
    Halvorsen S; Skjønsberg OH; Godal HC
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):133-7. PubMed ID: 8457641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low molecular weight fibrin degradation products on endothelial cells in culture.
    Busch C; Gerdin B
    Thromb Res; 1981 Apr 1-15; 22(1-2):33-9. PubMed ID: 7292445
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired EDRF production by endothelial cells exposed to fibrin monomer and FDP.
    Freedman JE; Fabian A; Loscalzo J
    Am J Physiol; 1995 Feb; 268(2 Pt 1):C520-6. PubMed ID: 7532361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight fibrinogen degradation products stimulate the release of growth factors from endothelial cells.
    Lorenzet R; Sobel JH; Bini A; Witte LD
    Thromb Haemost; 1992 Sep; 68(3):357-63. PubMed ID: 1440505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis.
    Naito M; Stirk CM; Smith EB; Thompson WD
    Thromb Res; 2000 Apr; 98(2):165-74. PubMed ID: 10713318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis.
    Guo F; Liu J; Wang C; Liu N; Lu P
    Biochem Biophys Res Commun; 2009 Dec; 390(3):942-6. PubMed ID: 19852936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin-mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction.
    Rowland FN; Donovan MJ; Picciano PT; Wilner GD; Kreutzer DL
    Am J Pathol; 1984 Dec; 117(3):418-28. PubMed ID: 6507588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of the inhibitory effect of fibrinogen and its degradation products on fibrin polymerization.
    Belitser VA; Lugovskoy EV; Musjalkovskaja AA; Gogolinskaja GK
    Thromb Res; 1982 Aug; 27(3):261-9. PubMed ID: 6291191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.